|
Quotes & Info
|
| RPBIF > SEC Filings for RPBIF > Form 8-K on 9-Nov-2012 | All Recent SEC Filings |
9-Nov-2012
Other Events, Financial Statements and Exhibits
On November 7, 2012, Response Biomedical Corp. (the "Company") announced by press release that the Company has received CE mark for their D-dimer Point of Care ("POC") assay for the European market.
(d) Exhibits.
Exhibit Number Description
99.1 Press release of Response Biomedical Corp. dated
November 7, 2012
|
|
|